Analyze Diet
Journal of clinical microbiology1978; 8(1); 54-60; doi: 10.1128/jcm.8.1.54-60.1978

Radioimmunoassay for quantitation of antibodies to alphaviruses with staphylococcal protein A.

Abstract: A radioimmunoassay (RIA) procedure is described for measuring antibodies to alphaviruses in human and other mammalian sera. The test employed protein Abearing Staphylococcus aureus as a solid-phase immunoadsorbent for (3)H-labeled viruses complexed with immunoglobulin G. Using antibodies produced in humans and guinea pigs, the RIA procedure clearly differentiated among antibodies to Venezuelan, western, and eastern equine encephalomyelitis viruses. Sensitivity of the RIA depended on the concentrations of labeled viruses employed. The dilution of serum that effected binding of 50% of the (3)H-labeled virus (determined by probit analysis) was consistently higher than the neutralizing antibody titer determined by a conventional plaque reduction neutralization test using 80% plaque reduction end points. In addition, sera from 73 individuals were screened for seroconversion following live attenuated Venezuelan equine encephalomyelitis virus vaccine (strain TC-83) inoculation, by RIA using a single serum dilution (1:80); results were identical with seroconversions identified by plaque reduction neutralization test. Hyperimmune Venezuelan equine encephalomyelitis virus sera from a number of mammalian species were successfully titrated by RIA; the species tested were human, guinea pig, white rat, rabbit, burro, dog, monkey, sheep, and cotton rat. The protein A-mediated RIA is a rapid, sensitive, specific, and precise serological tool for measuring antibodies to surface antigens of alphaviruses, and should allow the subsequent development of a competitive binding RIA to measure antigenic potency of inactivated alphavirus vaccines.
Publication Date: 1978-07-01 PubMed ID: 566768PubMed Central: PMC275114DOI: 10.1128/jcm.8.1.54-60.1978Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article describes a method for measuring antibodies to alphaviruses in various mammals using a radioimmunoassay procedure.

Radioimmunoassay Procedure

The radioimmunoassay procedure is a laboratory method used to measure very small amounts of substances in the blood, such as hormones and drugs, depending on the specific antibodies they contain. In this particular study, the focus was on using the procedure for measuring antibodies to alphaviruses.

  • This test utilized protein A-bearing Staphylococcus aureus as a solid-phase immunoadsorbent for radioactive-labelled viruses complexed with immunoglobulin G.
  • Immunoglobulin G (IgG) is the most common type of antibody found in blood circulation, and it helps protect the body from infection.
  • The researchers used antibodies produced in humans and guinea pigs for the radioimmunoassay procedure.

Antibody Differentiation

The procedure was successful in differentiating between antibodies to Venezuelan, western, and eastern equine encephalomyelitis viruses which are types of alphaviruses.

  • The sensitivity of the assay depends on the concentrations of labeled viruses used in the test.
  • The investigation noted that the serum dilution which effected 50% binding of the radioactive virus was consistently higher than the inherent neutralizing antibody titer – a measurement of how much neutralizing antibody an organism has produced.

Seroconversion Screening

Following this, sera from 73 individuals were screened for seroconversion, which refers to the time period during an infection when antibodies develop and become detectable in the blood, after being inoculated with a live attenuated Venezuelan equine encephalomyelitis virus vaccine.

  • The researchers used a single serum dilution level (1:80) in the radioimmunoassay.
  • The results using the radioimmunoassay were identical with the results achieved via the conventional plaque reduction neutralization test, confirming the effectiveness of the radioimmunoassay procedure.

Applications Across Mammalian Species

The researchers managed to successfully titrate – or determine the concentration of – hyperimmune Venezuelan equine encephalomyelitis virus sera from a variety of mammalian species.

  • The species tested included humans, guinea pigs, white rats, rabbits, burros, dogs, monkeys, sheep, and cotton rats.

A Promising Serological Tool

This study suggests that the protein A-mediated radioimmunoassay is a speedy, sensitive, specific, and precise serological tool to measure antibodies to the surface antigens of alphaviruses.

  • Antigens are substances which prompt the production of antibodies by the immune system.
  • This method could pave the way for the development of a competitive binding radioimmunoassay to measure the antigenic potency of inactivated alphavirus vaccines.

Cite This Article

APA
Jahrling PB, Hesse RA, Metzger JF. (1978). Radioimmunoassay for quantitation of antibodies to alphaviruses with staphylococcal protein A. J Clin Microbiol, 8(1), 54-60. https://doi.org/10.1128/jcm.8.1.54-60.1978

Publication

ISSN: 0095-1137
NlmUniqueID: 7505564
Country: United States
Language: English
Volume: 8
Issue: 1
Pages: 54-60

Researcher Affiliations

Jahrling, P B
    Hesse, R A
      Metzger, J F

        MeSH Terms

        • Animals
        • Antibodies, Viral / analysis
        • Antigen-Antibody Complex
        • Arboviruses / immunology
        • Encephalitis Virus, Venezuelan Equine / immunology
        • Guinea Pigs / immunology
        • Humans
        • Immune Sera / analysis
        • Immunosorbents
        • Mammals / immunology
        • Neutralization Tests
        • Radioimmunoassay / methods
        • Staphylococcal Protein A

        References

        This article includes 16 references
        1. J Immunol. 1968 May;100(5):921-6
          pubmed: 4171942
        2. Eur J Immunol. 1974 Jan;4(1):29-33
          pubmed: 4137309
        3. Infect Immun. 1974 May;9(5):924-30
          pubmed: 4824635
        4. Immunochemistry. 1970 Jan;7(1):124-7
          pubmed: 4984589
        5. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(6):673-82
          pubmed: 4994085
        6. J Immunol. 1970 Jan;104(1):140-7
          pubmed: 4983526
        7. J Immunol. 1969 Oct;103(4):828-33
          pubmed: 4981688
        8. J Immunol. 1975 Dec;115(6):1617-24
          pubmed: 1102604
        9. J Gen Virol. 1976 Jul;32(1):121-8
          pubmed: 956785
        10. Infect Immun. 1975 Nov;12(5):1206-10
          pubmed: 1193729
        11. J Infect Dis. 1975 Dec;132(6):667-76
          pubmed: 1202111
        12. J Immunol. 1977 Jul;119(1):193-8
          pubmed: 68969
        13. J Clin Microbiol. 1977 Sep;6(3):238-43
          pubmed: 20452
        14. Infect Immun. 1977 Sep;17(3):475-82
          pubmed: 409673
        15. Med Microbiol Immunol. 1977 May 18;163(1):25-35
          pubmed: 875885
        16. J Immunol. 1976 Jul;117(1):136-42
          pubmed: 58931

        Citations

        This article has been cited 2 times.
        1. Ascher MS, Jahrling PB, Harrington DG, Kishimoto RA, McGann VG. Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Clin Exp Immunol 1980 Aug;41(2):225-36.
          pubmed: 7438552
        2. Kronvall G, Simmons A, Myhre EB, Jonsson S. Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci. Infect Immun 1979 Jul;25(1):1-10.
          doi: 10.1128/iai.25.1.1-10.1979pubmed: 383609google scholar: lookup